BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

Active Motif Acquires SwitchGear Genomics Further Expanding Gene Regulation Product Offerings


3/22/2013 9:59:05 AM

March 21, 2013 – Active Motif, a leading provider of kits and reagents for the study of epigenetic phenomena, today announced the acquisition of privately owned SwitchGear Genomics, Inc. Founded in 2006 by Stanford scientists Shelley Force Aldred, Nathan Trinklein and Richard Myers, SwitchGear Genomics is a leading provider of research products for studying regulatory elements in the human genome.

“There is a strong scientific connection between epigenetics and gene regulation, and the combination of our technologies will create some very exciting possibilities for our customers,” said Joe Fernandez, CEO of Active Motif. “SwitchGear Genomics has a unique combination of expertise in computational regulatory element identification, experimental validation and data analysis that offers the scientist new and innovative high-throughput tools for studying regulatory element function across the genome.” He continued, “Our goal at Active Motif is to make cutting-edge research accessible to the wider life science community. Combining our innovative products with SwitchGear’s tools and expertise will give us the most comprehensive portfolio of gene regulation products available today.”

“The complementary strengths of the SwitchGear and Active Motif R&D teams put us in a unique position to support researchers across a broad spectrum of gene regulation research projects. This integration will enable Active Motif to expand its unique offering of research tools and genome-wide services for drug discovery,” added Theodore DeFrank, President of Active Motif.

About Active Motif

Active Motif, Inc. is dedicated to developing, manufacturing and delivering epigenetics-based research tools to analyze nuclear function. Its customers include life scientists from academic and government institutions; biotechnology and pharmaceutical companies; hospitals and reference laboratories. Active Motif operates globally through its corporate headquarters in Carlsbad, California; European headquarters in La Hulpe, Belgium; Asian headquarters in Tokyo, Japan and a worldwide network of sales and support offices. Active Motif applies a multi-disciplinary approach to create new and modify existing technologies to meet the current and future needs of life science researchers.



Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES